Sustained or extended release phenylephrine?

Thread view:

Enable EMail Alerts

Start New Thread

Thread rating:

Philip Sorensen - 24 May 2006 00:07 GMT

I'm working on a project looking at activity among pharma companies to move
away from pseudoephedrine to phenylephrine.

Does anyone have any knowledge of what some of the majors are doing here?
In particular, I am curious as to whether anyone is working on an extended
release version of phenylephrine for upper respiratory products, since it
doesn't last as long as pseudoephedrine.

Many thanks.

Philip Sorensen
==
Advanced Technology Innovations, Inc.
100 Petaluma Blvd. N, #303
Petaluma, CA 94952
Ph: 707-285-2020 Fx: 707-988-2616
Email: philip@atiincusa.com
http://www.atiincusa.com

Reply to this Message

Salmon Egg - 24 May 2006 02:04 GMT

On 5/23/06 4:07 PM, in article C098E3CB.2C1DE%philip@atiincusa.com, "Philip
Sorensen" <philip@atiincusa.com> wrote:

> I'm working on a project looking at activity among pharma companies to move
> away from pseudoephedrine to phenylephrine.
[quoted text clipped - 3 lines]
> release version of phenylephrine for upper respiratory products, since it
> doesn't last as long as pseudoephedrine.

Cynical me! Could it be that they are trying to get new patents and to
extend others in order to make MONEY at the expense of patients?

Bill
-- Ferme le Bush

Reply to this Message